T3 Pharma, a biotech start-up company of the University of Basel with a focus on immuno-oncology, has been named “2018 Science Start-Up of the Year” by Falling Walls Venture. The award honors the scientist-entrepreneurs for their breakthrough business model in bacterial cancer therapy.
The function of images and their epistemological value are the focus of a new fellowship program at the University of Basel, funded by the NOMIS Foundation. The first fellows began their research projects this fall.
Nine research projects involving Basel-based researchers in the field of personalized health will receive more than CHF 14 million over the next three years.
